Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
DL-erythro Sphinganine (d18:0) is a precursor of ceramide and sphingosine as well as a substrate of sphingosine kinases, which generate sphinganine-1-phosphate (Item No. 22500).1 Sphinganine levels increase significantly in response to certain mycotoxins, including fumonisins as well as in some cancers.2,3,4 This product is a mixture of sphinganine (d18:0) (Item No. 10007945), L-erythro sphinganine (d18:0) (Item No. 24374), D-threo sphinganine (d18:0) (Item No. 24375), and L-threo sphinganine (d18:0). [Matreya, LLC. Catalog No. 1324]
WARNING This product is not for human or veterinary use.
1. Differential roles of de novo sphingolipid biosynthesis and turnover in the “Burst” of free sphingosine and sphinganine, and their 1-
2. Biodiversity of sphingoid bases ("sphingosines") and related amino alcohols. J. Lipid Res. 49(8), 1621-1639 (2008).
3. Biomarkers of exposure to fumonisin mycotoxins: A review. Food Addit. Contam. 24(10), 1196-1201 (2007).
4. Altered sphingolipid metabolism induced by tumor hypoxia -